Ironwood Pharmaceuticals IRWD
NASDAQ IRWD
$4.16 +0.04 (+0.97%)
At close: Sep 29, 2026 · 4:00 PM EDT

Ironwood Pharmaceuticals (IRWD) EBITDA Margin (2010 - 2026)

Updated

Ironwood Pharmaceuticals (IRWD) posted EBITDA Margin of 70.56% for Q2 2026, up 16.84 percentage points from 53.72% a year earlier and up 2.01 percentage points from the prior quarter.

Analysis

Ironwood Pharmaceuticals (IRWD) EBITDA Margin (2010 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, EBITDA Margin at Ironwood Pharmaceuticals was 60.62%, up 36.22 percentage points year-over-year; for FY2025, it was 33.63%, up 6.79 percentage points from FY2024.

  • Annual EBITDA Margin shows a five-year change of -3.65 percentage points (FY2020 to FY2025).
  • In prior years, Ironwood Pharmaceuticals' EBITDA Margin was 26.84% in FY2024 (+240.11 pp), -213.27% in FY2023 (-274.58 pp), 61.31% in FY2022 (+4.81 pp) and 56.50% in FY2021 (+19.21 pp).
  • The Q2 2026 figure stands as the highest quarterly EBITDA Margin since Q4 2017.
  • On a year-over-year basis, EBITDA Margin increased in five of the last eight quarters, with an average year-over-year change of +13.27 percentage points.
  • The strongest year-over-year quarter for EBITDA Margin in the past five years was Q2 2024, with a gain of 1035.42 percentage points; the weakest was Q2 2023, with a drop of 1066.04 percentage points.
  • According to Business Quant data, EBITDA Margin for the three prior quarters was 68.56% (Q1 2026), 15.23% (Q4 2025) and 62.23% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 35.95%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 49.01%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 6.02%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 33.11%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 46.01%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -124.26%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 39.16%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 39.10%
10 Ironwood Pharmaceuticals 680.79 Mn 25.33 Mn - 70.56%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 70.56%
Mar 31, 2026 68.56%
Dec 31, 2025 15.23%
Sep 30, 2025 62.23%
Jun 30, 2025 53.72%
Mar 31, 2025 -69.58%
Dec 31, 2024 35.32%
Sep 30, 2024 28.54%
Jun 30, 2024 27.00%
Mar 31, 2024 15.40%
Dec 31, 2023 32.41%
Sep 30, 2023 35.63%
Jun 30, 2023 -1,008.43%
Mar 31, 2023 58.03%
Dec 31, 2022 64.09%
Sep 30, 2022 63.36%
Jun 30, 2022 57.61%
Mar 31, 2022 59.68%
Dec 31, 2021 48.62%
Sep 30, 2021 63.16%
API Access

Ironwood Pharmaceuticals EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=IRWD&period=max&api_key=YOUR_API_KEY